BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 27686204)

  • 1. [Attendance in the Norwegian Breast Cancer Screening Programme].
    Sebuødegård S; Sagstad S; Hofvind S
    Tidsskr Nor Laegeforen; 2016 Sep; 136(17):1448-51. PubMed ID: 27686204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mammography screening in the county of Fyn. November 1993-December 1999.
    Njor SH; Olsen AH; Bellstrøm T; Dyreborg U; Bak M; Axelsson C; Graversen HP; Schwartz W; Lynge E
    APMIS Suppl; 2003; (110):1-33. PubMed ID: 12739252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lower attendance rates in immigrant versus non-immigrant women in the Norwegian Breast Cancer Screening Programme.
    Bhargava S; Tsuruda K; Moen K; Bukholm I; Hofvind S
    J Med Screen; 2018 Sep; 25(3):155-161. PubMed ID: 29059006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
    Lynge E
    APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mammography screening in Rogaland--the first round].
    Iversen BF; Eriksen L
    Tidsskr Nor Laegeforen; 2000 Nov; 120(27):3241-5. PubMed ID: 11187161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effectiveness of population-based breast cancer screening programme].
    Szynglarewicz B; Matkowski R; Kasprzak P; Kotowska J; Forgacz J; Pudełko M; Kornafel J
    Pol Merkur Lekarski; 2009 Feb; 26(152):117-20. PubMed ID: 19388515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attending the breast screening programme after breast cancer treatment: a population-based study.
    de Munck L; Kwast A; Reiding D; de Bock GH; Otter R; Willemse PH; Siesling S
    Cancer Epidemiol; 2013 Dec; 37(6):968-72. PubMed ID: 24075800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Participation in Swiss mammography screening programmes: key role of physicians].
    Bulliard JL; de Landtsheer JP; Levi F
    Praxis (Bern 1994); 2005 Sep; 94(36):1381-7. PubMed ID: 16190371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pattern of participation in a cohort aged 50-60 years at first invitation to the service-screening programme with mammography in Stockholm county, Sweden.
    Törnberg S; Kemetli L; Svane G; Rosén M; Stenbeck M; Nyström L
    Prev Med; 2005; 41(3-4):728-33. PubMed ID: 16137757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of invitation schemes on breast cancer screening coverage: A cohort study from Copenhagen, Denmark.
    Jacobsen KK; von Euler Chelpin M; Vejborg I; Lynge E
    J Med Screen; 2017 Mar; 24(1):20-26. PubMed ID: 27206815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural history of breast cancers detected in the Swedish mammography screening programme: a cohort study.
    Zahl PH; Gøtzsche PC; Mæhlen J
    Lancet Oncol; 2011 Nov; 12(12):1118-24. PubMed ID: 21996169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cumulative attendance, assessment and cancer detection rate over four screening rounds in five English breast-screening programmes: a retrospective study.
    Wallis M; Neilson F; Hogarth H; Whitaker C; Faulkner K
    J Public Health (Oxf); 2007 Sep; 29(3):275-80. PubMed ID: 17522078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer screening programme as setting for an adjunct research project: effect on programme attendance.
    Gram IT; Lund E
    J Med Screen; 2008; 15(1):44-5. PubMed ID: 18416955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Incidence of breast cancer before and after implementation of mammography screening].
    Hofvind S; Sørum R; Haldorsen T; Langmark F
    Tidsskr Nor Laegeforen; 2006 Nov; 126(22):2935-8. PubMed ID: 17117191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using the European guidelines to evaluate the Norwegian Breast Cancer Screening Program.
    Hofvind S; Geller B; Vacek PM; Thoresen S; Skaane P
    Eur J Epidemiol; 2007; 22(7):447-55. PubMed ID: 17594526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tailored Breast Screening Trial (TBST)].
    Paci E; Mantellini P; Giorgi Rossi P; Falini P; Puliti D;
    Epidemiol Prev; 2013; 37(4-5):317-27. PubMed ID: 24293498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Norwegian Breast Cancer Screening Program: re-attendance related to the women's experiences, intentions and previous screening result.
    Hofvind SS; Wang H; Thoresen S
    Cancer Causes Control; 2003 May; 14(4):391-8. PubMed ID: 12846372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer screening programmes: challenging the coexistence with opportunistic mammography.
    Ouédraogo S; Dabakuyo-Yonli TS; Amiel P; Dancourt V; Dumas A; Arveux P
    Patient Educ Couns; 2014 Dec; 97(3):410-7. PubMed ID: 25282326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asymptomatic breast cancer in non-participants of the national screening programme in Norway: a confounding factor in evaluation?
    Hoff SR; Klepp O; Hofvind S
    J Med Screen; 2012 Dec; 19(4):177-83. PubMed ID: 23486698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of the Norwegian breast cancer screening program.
    van Luijt PA; Heijnsdijk EA; de Koning HJ
    Int J Cancer; 2017 Feb; 140(4):833-840. PubMed ID: 27861849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.